Drug Index


Indication :

  • HIV infection

Dosing :

Available as (600 mg/300 mg/50 mg) tablet.
>40 kg: 1 tablet a day.
<40 kg: Safety not established.

Adverse Effect :

Please see the adverse effects of abacavir, lamivudine and dolutegravir.

Hepatic Dose :

Abacavir: Moderate to severe hepatic impairment: Use is contraindicated
Lamivudine: No dosage adjustments required. Use with caution in patients with decompensated liver disease.
Dolutegravir: Mild to moderate hepatic impairment: No dosage adjustment necessary. Severe hepatic impairment: Drug use not recommended.
03/21/2024 00:37:11 Abacavir/Lamivudine/Dolutegravir
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0